Workflow
倍舒痕®硅凝胶疤痕贴
icon
Search documents
京东健康首发美纳里尼新品倍舒痕硅凝胶疤痕贴
Zheng Quan Ri Bao· 2025-09-12 13:49
Core Insights - The launch of Menarini's new product, the Beshuhen® silicone gel scar patch, on JD Health marks a significant step in scar management and reflects the growing market demand for effective scar treatment solutions [2][3] - The scar management market is experiencing rapid growth, with JD Health reporting a compound annual growth rate of 62% in scar removal market sales from 2019 to 2024 [2] - The Beshuhen® silicone gel scar patch incorporates multiple technological innovations to meet consumer demands for adhesion, durability, soothing care, and natural appearance [2] Company and Industry Developments - Menarini aims to leverage its global clinical research capabilities and local insights in collaboration with JD Health to promote a comprehensive scar management approach focused on early prevention and intervention [2][3] - JD Health plans to continue its partnership with Menarini and other global medical device brands to establish a new product launch IP aimed at transforming scar management from reactive repair to proactive prevention [3]
京东健康首发美纳里尼新品倍舒痕®硅凝胶疤痕贴
Core Insights - The launch of the new product,倍舒痕®硅凝胶疤痕贴, by Menarini on JD Health marks a significant step in scar management, leveraging Menarini's clinical research capabilities and JD Health's digital marketing ecosystem [1][2] - The scar management market is experiencing rapid growth, with a projected compound annual growth rate (CAGR) of 62% in sales from 2019 to 2024 according to the "China Skin Scar White Paper" released by JD Health and Menarini [1] - The new product features multiple technological innovations to meet consumer demands for adhesion, durability, soothing care, and natural appearance [1] Company and Industry Developments - Menarini aims to enhance consumer access to innovative scar management solutions through collaboration with JD Health, promoting early and scientific scar management [2] - JD Health plans to continue its partnership with global medical device brands to establish a new product launch IP, focusing on transforming scar management from passive repair to scientific prevention [2]